Results 151 to 160 of about 1,597,616 (181)

Rocuronium-Induced Rhabdomyolysis: A Case Report and Literature Review. [PDF]

Cureus
Liang M, Ji Z, Tang J, Hu Y, Nie G.
europepmc   +1 more source

Probable Malignant Hyperthermia Presenting With Refractory Hypotension in a Young Trauma Patient: A Case Report. [PDF]

A A Pract
Azar MY, Azar JH, Azar AE.
europepmc   +1 more source

Review and Update of Anesthetic Management for Electroconvulsive Therapy: A Narrative Review. [PDF]

Neuropsychiatr Dis Treat
Singh A, Davis F, Anwar AI, Hirsch JD, Barrie SA, Tirumala S, Shekoohi S, Ahmadzadeh S.   +7 more
europepmc   +1 more source

Interactions between Org9426 and other non-depolarizing neuromuscular blocking agents in rats in vivo

, 1993
openaire   +1 more source

Disposition and effects of some non-depolarizing neuromuscular blocking agents in animal and man

, 1976
openaire   +1 more source

Neuromuscular blocking agents and reversal agents

Anaesthesia and Intensive Care Medicine, 2005
The neuromuscular blocking agents in routine clinical use may be classed as depolarizing or nondepolarizing. Suxamethonium is the only example of the depolarizing group and is an agonist at the neuromuscular receptor.
Brian J Pollard
exaly   +11 more sources

Some of the next articles are maybe not open access.

Related searches:

Depolarizing Neuromuscular Blocking Agents

2017
Succinylcholine was first introduced into clinical practice in the 1950s, and is currently the only depolarizing neuromuscular blocker in use. It is unique among the drugs used for muscle relaxation in its rapid onset and short duration of action. These characteristics account for its extensive use in scenarios requiring emergency control of the airway.
Caroline S. Gross, Zhiling Xiong
exaly   +2 more sources

Interactions between ORG9426 and other non-depolarizing neuromuscular blocking agents in ratsin vivo

Journal of Anesthesia, 1992
In this study, combined neuromuscular blocking effects of ORG9426 with other non-depolarizing neuromuscular blocking agents were investigated. About 20% steady state neuromuscular block was established by a continuous infusion of one of 6 neuromuscular blocking agents (ORG9426, vecuronium, pancuronium, pipecuronium, d-tubocurarine and metocurine). Then
Kazuhiko Watanabe
exaly   +3 more sources

A study in vitro of new short-acting, non-depolarizing neuromuscular blocking agents

Biochemical Pharmacology, 1969
Abstract Presently available short-acting, depolarizing myoneural blocking agents have significant side effects such as increased intraocular tension, cardiac arrhythmias desensitization of the postjunctional membrane, skeletal muscle injury and muscle pains. Non-depolarizing blocking drugs do not produce profound blocks of short duration.
S Ginsburg, Sara Ginsburg
exaly   +3 more sources

Interactions of Volatile Anesthetics with Non-Depolarizing Neuromuscular Blocking Agents

1995
Drug interactions involving neuromuscular blocking agents are divided into two classes: one is interaction between neuromuscular blocking drugs and other classes of drug.The second is interactions with neuromuscular blocking agents each other.
Kazuaki Fukushima
exaly   +2 more sources